Many papers demonstrated associations between CSF and serum NFL levels and formation of acute MS lesions (i.e., contrast-enhancing lesions [CELs] on brain MRI; refs. 2, 3) or an association of therapy-induced inhibition of serum/CSF NFL concentration with therapeutic effect on CELs or MS relapses (4). Here, NEFL is linked to myeloid sarcoma.